| articulation disorder | ||||
| Disease ID | 1841 |
|---|---|
| Disease | articulation disorder |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:4) HP:0000175 | Palatoschisis | 4 HP:0000220 | Velopharyngeal insufficiency | 1 HP:0100021 | Cerebral palsy | 1 HP:0010296 | Ankyloglossia | 1 |
| Disease ID | 1841 |
|---|---|
| Disease | articulation disorder |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0003910 | carbamazepine | D002220 | 298-46-4 | articulation disorders | MESH:D001184 | marker/mechanism | 16140591 | ||
| C0003910 | ceftazidime | D002442 | 78439-06-2 | articulation disorders | MESH:D001184 | marker/mechanism | 17325906 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |